Insider Cluster (3 insiders) ·Filed Apr 24, 2026

UTHR

UNITED THERAPEUTICS Corp
NEUTRAL
Impact 2/10
Horizonimmediate Processed5mo ago
Insider cluster: 3 insiders, $3.5M total
Actionable Insight • Neutral

This insider cluster is routine and non-material. No trading action warranted. Monitor for any upcoming SEC filings or clinical/regulatory updates for the company.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d ⚠ clustered
UTHR ▼ -6.64% at T+60d
NEUTRAL call ✗ call lost -6.64% · α vs SPY -10.59% · entry $567.00 → $529.34
Entry anchored
Apr 23, 03:59 PM ET
via exchange tick
T+1d
-0.07%
call -0.07% · α -0.23%
$566.62
settled 5mo ago
T+5d
+0.77%
call +0.77% · α -0.14%
$571.35
settled 5mo ago
T+20d
-0.20%
call -0.20% · α -4.23%
$565.87
settled 4mo ago
T+60d
-6.64%
call -6.64% · α -10.59%
$529.34
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Three insiders at United Therapeutics (UTHR), including the CEO and CFO, sold a total of ~$3.48M in stock over a five-day period. All sales were preceded by derivative exercises (stock options) and represent routine cash-out transactions. At $24.9B market cap, the total sales are negligible (0.014% of market cap), carrying no material signal.

Key Financial Metrics

Direction
selling
Total Value
$3.5M
Insiders
3

Key Facts

  • CEO Martine Rothblatt sold 2,306 shares for ~$1.1M across multiple days.
  • CFO James Edgemond sold 1,716 shares for ~$971K.
  • Director Christopher Patusky sold 2,910 shares for ~$1.66M.
  • All sales were accompanied by stock option exercises at $0 or near-market prices.
  • Total open-market sales of ~$3.48M represent 0.014% of UTHR's $24.9B market cap.

Financial Impact

Total insider selling of $3.48M, immaterial relative to $24.9B market cap.

dilutioninsider ownership

Risk Factors

  • No material risks identified from this insider activity.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
76% bullish (21 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-UTHR-1777494766335
91 reports for UTHR
Performance horizon
80% Hit rate 4 of 5 directional calls best @ T+60▲ +5.53%Feb 25, 2026
Filters
Rows
Reports for UTHR — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
Insider Cluster
NEUTRAL ★ 2/10
$500.35 $497.31▼ −0.61%▼ −2.72%$571.38 (+14.20%)
Sep 11, 2026
21d ago
Insider Cluster
NEUTRAL ★ 3/10
$497.11 $494.63▼ −0.50%▼ −0.28%$571.38 (+14.94%)
Sep 10, 2026
22d ago
Insider Cluster
MIXED ★ 4/10
$503.86 $497.27▼ −1.31%▼ −0.81%$571.38 (+13.40%)
Sep 9, 2026
23d ago
Insider Cluster
NEUTRAL ★ 3/10
$506.82 $498.48▼ −1.65%▼ −0.99%$571.38 (+12.74%)
Sep 4, 2026
28d ago
Insider Cluster
NEUTRAL ★ 2/10
$487.61 $502.70▲ +3.09%▲ +4.30%$571.38 (+17.18%)
Sep 3, 2026
29d ago
Insider Cluster
NEUTRAL ★ 2/10
$488.16 $497.11▲ +1.83%▲ +2.98%$571.38 (+17.05%)
Aug 28, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$515.46 $487.61▼ −5.40%▼ −5.51%$571.38 (+10.85%)
Aug 27, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$527.91 $492.02▼ −6.80%▼ −6.03%$571.38 (+8.23%)
Aug 26, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$516.68 $492.02▼ −4.77%▼ −4.65%$571.38 (+10.59%)
Aug 25, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$516.68 $492.02▼ −4.77%▼ −4.65%$571.38 (+10.59%)
Showing 10 of 91

US Market Status

Market Open — Closes in 6h 27m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Apr 29, 2026